▶ 調査レポート

進行性再発型多発性硬化症（RMS）治療の世界市場 2020年
• 英文タイトル：Global Progressive Relapsing Multiple Sclerosis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。進行性再発型多発性硬化症（RMS）治療の世界市場 2020年 / Global Progressive Relapsing Multiple Sclerosis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / GIR201114950資料のイメージです。• レポートコード：GIR201114950
• 出版社/出版日：GlobalInfoResearch / 2020年10月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、101ページ
• 納品方法：Eメール
• 産業分類：医薬品・医療
• 販売価格（消費税別）
  Single User￥515,040 (USD3,480)▷ お問い合わせ
  Multi User￥772,560 (USD5,220)▷ お問い合わせ
  Corporate User￥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本書では、進行性再発型多発性硬化症（RMS）治療の世界市場を調査対象にし、進行性再発型多発性硬化症（RMS）治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別分析（クリニック、病院、その他）、市場予測（2021年～2025年）情報などを整理しました。
・市場概要
・企業情報：Cognosci Inc、VivaCell Biotechnology Espana SL、Genzyme Corp、MedImmune LLC
・企業別売上、市場シェア
・進行性再発型多発性硬化症（RMS）治療の地域別市場分析
・進行性再発型多発性硬化症（RMS）治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ
・進行性再発型多発性硬化症（RMS）治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど
・進行性再発型多発性硬化症（RMS）治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど
・進行性再発型多発性硬化症（RMS）治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど
・進行性再発型多発性硬化症（RMS）治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど
・進行性再発型多発性硬化症（RMS）治療の種類別市場規模2015-2020：COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他
・進行性再発型多発性硬化症（RMS）治療の用途別市場規模2015-2020：クリニック、病院、その他
・進行性再発型多発性硬化症（RMS）治療の世界市場予測2021-2025：地域別、種類別、用途別
・調査の結果・結論

Market Overview
The global Progressive Relapsing Multiple Sclerosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Progressive Relapsing Multiple Sclerosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Progressive Relapsing Multiple Sclerosis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Progressive Relapsing Multiple Sclerosis Treatment market has been segmented into:
COG-133
GZ-402668
Inebilizumab
VCE-0032
Others

By Application, Progressive Relapsing Multiple Sclerosis Treatment has been segmented into:
Clinic
Hopital
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Progressive Relapsing Multiple Sclerosis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Progressive Relapsing Multiple Sclerosis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Progressive Relapsing Multiple Sclerosis Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Progressive Relapsing Multiple Sclerosis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Progressive Relapsing Multiple Sclerosis Treatment Market Share Analysis
Progressive Relapsing Multiple Sclerosis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Progressive Relapsing Multiple Sclerosis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Progressive Relapsing Multiple Sclerosis Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Progressive Relapsing Multiple Sclerosis Treatment are:
Cognosci Inc
VivaCell Biotechnology Espana SL
Genzyme Corp
MedImmune LLC

レポート目次

Table of Contents

1 Progressive Relapsing Multiple Sclerosis Treatment Market Overview
1.1 Product Overview and Scope of Progressive Relapsing Multiple Sclerosis Treatment
1.2 Classification of Progressive Relapsing Multiple Sclerosis Treatment by Type
1.2.1 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type in 2019
1.2.3 COG-133
1.2.4 GZ-402668
1.2.5 Inebilizumab
1.2.6 VCE-0032
1.2.7 Others
1.3 Global Progressive Relapsing Multiple Sclerosis Treatment Market by Application
1.3.1 Overview: Global Progressive Relapsing Multiple Sclerosis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hopital
1.3.4 Others
1.4 Global Progressive Relapsing Multiple Sclerosis Treatment Market by Regions
1.4.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Progressive Relapsing Multiple Sclerosis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Cognosci Inc
2.1.1 Cognosci Inc Details
2.1.2 Cognosci Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cognosci Inc SWOT Analysis
2.1.4 Cognosci Inc Product and Services
2.1.5 Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 VivaCell Biotechnology Espana SL
2.2.1 VivaCell Biotechnology Espana SL Details
2.2.2 VivaCell Biotechnology Espana SL Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 VivaCell Biotechnology Espana SL SWOT Analysis
2.2.4 VivaCell Biotechnology Espana SL Product and Services
2.2.5 VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Genzyme Corp
2.3.1 Genzyme Corp Details
2.3.2 Genzyme Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Genzyme Corp SWOT Analysis
2.3.4 Genzyme Corp Product and Services
2.3.5 Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 MedImmune LLC
2.4.1 MedImmune LLC Details
2.4.2 MedImmune LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 MedImmune LLC SWOT Analysis
2.4.4 MedImmune LLC Product and Services
2.4.5 MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Progressive Relapsing Multiple Sclerosis Treatment Players Market Share
3.2.2 Top 10 Progressive Relapsing Multiple Sclerosis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue and Market Share by Regions
4.2 North America Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
5 North America Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries
5.1 North America Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries (2015-2020)
5.2 USA Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries
6.1 Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries (2015-2020)
6.2 Germany Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries
7.1 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries (2015-2020)
7.2 China Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
8 South America Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries
8.1 South America Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Progressive Relapsing Multiple Sclerosis Treatment by Countries
9.1 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Progressive Relapsing Multiple Sclerosis Treatment Market Forecast by Type (2019-2024)
10.3 COG-133 Revenue Growth Rate (2015-2025)
10.4 GZ-402668 Revenue Growth Rate (2015-2025)
10.5 Inebilizumab Revenue Growth Rate (2015-2025)
10.6 VCE-0032 Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Progressive Relapsing Multiple Sclerosis Treatment Market Segment by Application
11.1 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Application (2015-2020)
11.2 Progressive Relapsing Multiple Sclerosis Treatment Market Forecast by Application (2019-2024)
11.3 Clinic Revenue Growth (2015-2020)
11.4 Hopital Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Forecast (2021-2025)
12.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Forecast (2021-2025)
12.2 Global Progressive Relapsing Multiple Sclerosis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Progressive Relapsing Multiple Sclerosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Cognosci Inc Corporate Information, Location and Competitors
Table 6. Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Major Business
Table 7. Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Cognosci Inc SWOT Analysis
Table 9. Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Product and Solutions
Table 10. Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. VivaCell Biotechnology Espana SL Corporate Information, Location and Competitors
Table 12. VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Major Business
Table 13. VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Total Revenue (USD Million) (2018-2019)
Table 14. VivaCell Biotechnology Espana SL SWOT Analysis
Table 15. VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Product and Solutions
Table 16. VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Genzyme Corp Corporate Information, Location and Competitors
Table 18. Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Major Business
Table 19. Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Genzyme Corp SWOT Analysis
Table 21. Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Product and Solutions
Table 22. Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. MedImmune LLC Corporate Information, Location and Competitors
Table 24. MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Major Business
Table 25. MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Total Revenue (USD Million) (2017-2018)
Table 26. MedImmune LLC SWOT Analysis
Table 27. MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Product and Solutions
Table 28. MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) by Players (2015-2020)
Table 30. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Players (2015-2020)
Table 31. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 32. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Regions (2015-2020)
Table 33. North America Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries (2015-2020)
Table 34. North America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries (2015-2020)
Table 35. Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 36. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 37. South America Progressive Relapsing Multiple Sclerosis Treatment Revenue by Countries (2015-2020)
Table 38. South America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries (2015-2020)
Table 39. Middle East and Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 40. Middle East and Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries (2015-2020)
Table 41. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) by Type (2015-2020)
Table 42. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Type (2015-2020)
Table 43. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Forecast by Type (2021-2025)
Table 44. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue by Application (2015-2020)
Table 45. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Application (2015-2020)
Table 46. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Forecast by Application (2021-2025)
Table 47. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Progressive Relapsing Multiple Sclerosis Treatment Picture
Figure 2. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type in 2019
Figure 3. COG-133 Picture
Figure 4. GZ-402668 Picture
Figure 5. Inebilizumab Picture
Figure 6. VCE-0032 Picture
Figure 7. Others Picture
Figure 8. Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Application in 2019
Figure 9. Clinic Picture
Figure 10. Hopital Picture
Figure 11. Others Picture
Figure 12. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries in 2019
Figure 45. China Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Type in 2019
Figure 62. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global COG-133 Revenue Growth Rate (2015-2020)
Figure 64. Global GZ-402668 Revenue Growth Rate (2015-2020)
Figure 65. Global Inebilizumab Revenue Growth Rate (2015-2020)
Figure 66. Global VCE-0032 Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Application (2015-2020)
Figure 69. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Application in 2019
Figure 70. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share Forecast by Application (2021-2025)
Figure 71. Global Clinic Revenue Growth Rate (2015-2020)
Figure 72. Global Hopital Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

以下、関連資料のご紹介
  • 一次進行型多発性硬化症治療の世界市場 2020年
    Global Primary Progressive Multiple Sclerosis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    GIR201114934 2020年10月 100Pages
    本書では、一次進行型多発性硬化症治療の世界市場を調査対象にし、一次進行型多発性硬化症治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、ラ...
  • 二次進行型多発性硬化症治療薬の世界市場 2020年
    Global Secondary Progressive Multiple Sclerosis Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    GIR201108305 2020年10月20日 139Pages
    本書では、二次進行型多発性硬化症治療薬の世界市場を調査対象にし、二次進行型多発性硬化症治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（イネビリズマブ、GLX-1112、DC-TAB...
  • 異染性白質ジストロフィー（MLD）治療の世界市場 2020年
    Global Metachromatic Leukodystrophy (MLD) Treatment Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    GIR201105167 2020年10月20日 103Pages
    本書では、異染性白質ジストロフィー（MLD）治療の世界市場を調査対象にし、異染性白質ジストロフィー（MLD）治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（AGT-183、DUOC-...
  • 人工関節感染症（PJI）治療の世界市場 2020年
    Global Prosthetic Joint Infections Treatment Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    GIR201107565 2020年10月20日 101Pages
    本書では、人工関節感染症（PJI）治療の世界市場を調査対象にし、人工関節感染症（PJI）治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（フシジン酸、酢酸レファムリン、MTF-101、...
  • 皮膚エリテマトーデス（CLE）治療の世界市場 2020年
    Global Cutaneous Lupus Erythematosus (CLE) Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    GIR201114113 2020年10月 100Pages
    本書では、皮膚エリテマトーデス（CLE）治療の世界市場を調査対象にし、皮膚エリテマトーデス（CLE）治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（局所、全身治療）、用途別分析（病院、ドラッグストア...
  • 神経内分泌腫瘍（NET）治療の世界市場 2020年
    Global Neuroendocrine Tumors (NETs) Treatment Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    GIR201105762 2020年10月20日 107Pages
    本書では、神経内分泌腫瘍（NET）治療の世界市場を調査対象にし、神経内分泌腫瘍（NET）治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ソマトスタチン類似体（SSA）、標的療法、その...
  • 全身型若年性特発性関節炎（JIA）治療の世界市場 2020年
    Global Systemic Idiopathic Juvenile Arthritis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    GIR201115228 2020年10月 101Pages
    本書では、全身型若年性特発性関節炎（JIA）治療の世界市場を調査対象にし、全身型若年性特発性関節炎（JIA）治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（アダリムマブバイオシミラー、カナキヌマブ、...
  • 外傷性脳損傷（TBI）治療の世界市場 2020年
    Global Traumatic Brain Injuries Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    GIR201115304 2020年10月 100Pages
    本書では、外傷性脳損傷（TBI）治療の世界市場を調査対象にし、外傷性脳損傷（TBI）治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（外科、薬物）、用途別分析（病院、神経内科医センター、薬局）、市場予...
  • 多発性内分泌腫瘍治療の世界市場 2020年
    Global Multiple Endocrine Neoplasia Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    GIR201114609 2020年10月 103Pages
    本書では、多発性内分泌腫瘍治療の世界市場を調査対象にし、多発性内分泌腫瘍治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（薬物治療、外科治療）、用途別分析（病院、クリニック、その他）、市場予測（202...
  • 結核診断・治療の世界市場 2020年
    Global Tuberculosis Diagnostics and Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    GIR201115313 2020年10月 124Pages
    本書では、結核診断・治療の世界市場を調査対象にし、結核診断・治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（皮膚テスト、実験室テスト）、用途別分析（病院、診療所、その他）、市場予測（2021年～20...
  • 一次進行型多発性硬化症治療の世界市場 2020年一次進行型多発性硬化症治療の世界市場 2020年 Market Overview The global Primary Progressive Multiple Sclerosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …
  • 二次進行型多発性硬化症治療薬の世界市場 2020年二次進行型多発性硬化症治療薬の世界市場 2020年 Market Overview The global Secondary Progressive Multiple Sclerosis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The…
  • 多発性内分泌腫瘍治療の世界市場 2020年多発性内分泌腫瘍治療の世界市場 2020年 Market Overview The global Multiple Endocrine Neoplasia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Multip…
  • 全身性硬化症治療の世界市場 2020年全身性硬化症治療の世界市場 2020年 Market Overview The global Systemic Sclerosis Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Systemic Sclero…
  • 進行性多巣性白質脳症（PML）治療薬の世界市場 2020年進行性多巣性白質脳症（PML）治療薬の世界市場 2020年 Market Overview The global Progressive Multifocal Leukoencephalopathy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…